tradingkey.logo

Teleflex Inc

TFX

122.630USD

-3.170-2.52%
Close 09/19, 16:00ETQuotes delayed by 15 min
5.42BMarket Cap
28.24P/E TTM

Teleflex Inc

122.630

-3.170-2.52%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
58 / 207
Overall Ranking
136 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 14 analysts
Hold
Current Rating
139.802
Target Price
+11.13%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 90.56%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 90.56%.
Undervalued
The company’s latest PE is 28.53, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 48.67M shares, decreasing 0.79% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.80M shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 7.38, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 780.89M, representing a year-over-year increase of 4.16%, while its net profit experienced a year-over-year increase of 53.15%.

Score

Industry at a Glance

Previous score
7.38
Change
0

Financials

7.31

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

6.64

Operational Efficiency

7.18

Growth Potential

9.08

Shareholder Returns

6.68

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 6.98, which is higher than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is 29.27, which is 26.52% below the recent high of 37.03 and -0.45% above the recent low of 29.40.

Score

Industry at a Glance

Previous score
6.98
Change
1.22

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 58/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Teleflex Inc is 135.00, with a high of 197.22 and a low of 120.00.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 14 analysts
Hold
Current Rating
139.802
Target Price
+11.13%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

118
Total
7
Median
8
Average
Company name
Ratings
Analysts
Teleflex Inc
TFX
14
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.29, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 131.48 and the support level at 121.83, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.29
Change
-0.33

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-2.064
Neutral
RSI(14)
42.873
Neutral
STOCH(KDJ)(9,3,3)
13.653
Sell
ATR(14)
3.136
Low Volatility
CCI(14)
-132.998
Sell
Williams %R
99.247
Oversold
TRIX(12,20)
0.209
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
125.152
Sell
MA10
127.927
Sell
MA20
127.925
Sell
MA50
121.401
Buy
MA100
122.093
Buy
MA200
141.316
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 110.13%, representing a quarter-over-quarter decrease of 0.35%. The largest institutional shareholder is The Vanguard, holding a total of 4.80M shares, representing 10.86% of shares outstanding, with 8.71% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
T. Rowe Price Investment Management, Inc.
6.22M
+0.71%
BlackRock Institutional Trust Company, N.A.
5.36M
+102.18%
The Vanguard Group, Inc.
Star Investors
5.07M
-8.26%
Janus Henderson Investors
4.33M
-17.75%
Atlanta Capital Management Company, L.L.C.
2.78M
+2.70%
UBS Financial Services, Inc.
3.31M
+1413.63%
State Street Global Advisors (US)
1.53M
-25.79%
Dimensional Fund Advisors, L.P.
867.86K
+69.46%
Cooke & Bieler, L.P.
1.06M
-1.95%
Geode Capital Management, L.L.C.
1.02M
-10.51%
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.21, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.05. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.21
Change
0
Beta vs S&P 500 index
1.05
VaR
+3.00%
240-Day Maximum Drawdown
+54.24%
240-Day Volatility
+36.89%
Return
Best Daily Return
60 days
+4.93%
120 days
+6.31%
5 years
+11.56%
Worst Daily Return
60 days
-3.39%
120 days
-8.16%
5 years
-21.69%
Sharpe Ratio
60 days
+0.43
120 days
-0.62
5 years
-0.57
Risk Assessment
Maximum Drawdown
240 days
+54.24%
3 years
+59.95%
5 years
+75.33%
Return-to-Drawdown Ratio
240 days
-0.90
3 years
-0.22
5 years
-0.18
Skewness
240 days
-3.49
3 years
-1.85
5 years
-1.39
Volatility
Realised Volatility
240 days
+36.89%
5 years
+30.54%
Standardised True Range
240 days
+3.46%
5 years
+5.42%
Downside Risk-Adjusted Return
120 days
-93.44%
240 days
-93.44%
Maximum Daily Upside Volatility
60 days
+26.86%
Maximum Daily Downside Volatility
60 days
+21.21%
Liquidity
Average Turnover Rate
60 days
+1.23%
120 days
+1.70%
5 years
--
Turnover Deviation
20 days
+13.01%
60 days
+11.35%
120 days
+53.86%

Peer Comparison

Healthcare Equipment & Supplies
Teleflex Inc
Teleflex Inc
TFX
6.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI